Aptus Capital Advisors, LLC Novartis Ag Transaction History

Aptus Capital Advisors, LLC

  • $5.23 Billion
  • Q2 2024

A detailed history of Aptus Capital Advisors, LLC transactions in Novartis Ag stock. As of the latest transaction made, Aptus Capital Advisors, LLC holds 4,616 shares of NVS stock, worth $525,993. This represents 0.01% of its overall portfolio holdings.

Number of Shares
4,616
Previous 4,564 1.14%
Holding current value
$525,993
Previous $441,000 11.34%
% of portfolio
0.01%
Previous 0.01%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024
BUY
$92.57 - $107.37 $4,813 - $5,583
52 Added 1.14%
4,616 $491,000
Q1 2024

May 15, 2024
BUY
$95.27 - $108.47 $59,162 - $67,359
621 Added 15.75%
4,564 $441,000
Q4 2023

Feb 13, 2024
SELL
$92.27 - $101.54 $16,793 - $18,480
-182 Reduced 4.41%
3,943 $398,000
Q3 2023

Nov 08, 2023
BUY
$94.73 - $105.13 $54,848 - $60,870
579 Added 16.33%
4,125 $420,000
Q2 2023

Aug 11, 2023
BUY
$92.52 - $104.91 $93,815 - $106,378
1,014 Added 40.05%
3,546 $357,000
Q1 2023

May 09, 2023
SELL
$80.03 - $92.81 $42,976 - $49,838
-537 Reduced 17.5%
2,532 $232,000
Q4 2022

Feb 13, 2023
BUY
$75.55 - $92.52 $1,964 - $2,405
26 Added 0.85%
3,069 $278,000
Q3 2022

Nov 02, 2022
BUY
$74.61 - $87.26 $20,219 - $23,647
271 Added 9.78%
3,043 $231,000
Q2 2022

Jul 29, 2022
BUY
$80.52 - $93.75 $3,703 - $4,312
46 Added 1.69%
2,772 $234,000
Q1 2022

May 04, 2022
BUY
$80.11 - $90.62 $11,135 - $12,596
139 Added 5.37%
2,726 $239,000
Q3 2021

Oct 27, 2021
SELL
$81.78 - $95.14 $572 - $665
-7 Reduced 0.27%
2,587 $212,000
Q2 2021

Jul 27, 2021
SELL
$85.24 - $94.15 $85 - $94
-1 Reduced 0.04%
2,594 $237,000
Q4 2020

Feb 10, 2021
BUY
$78.07 - $94.43 $78 - $94
1 Added 0.04%
2,595 $245,000
Q3 2020

Oct 19, 2020
SELL
$82.14 - $91.0 $1,396 - $1,547
-17 Reduced 0.65%
2,594 $225,000
Q2 2020

Jul 22, 2020
BUY
$80.93 - $91.1 $1,133 - $1,275
14 Added 0.54%
2,611 $228,000
Q1 2020

May 07, 2020
SELL
$70.67 - $99.01 $17,243 - $24,158
-244 Reduced 8.59%
2,597 $214,000
Q4 2019

Feb 10, 2020
BUY
$84.35 - $95.37 $337 - $381
4 Added 0.14%
2,841 $269,000
Q3 2019

Nov 12, 2019
SELL
$85.54 - $94.26 $2,052 - $2,262
-24 Reduced 0.84%
2,837 $246,000
Q2 2019

Aug 13, 2019
SELL
$75.4 - $92.8 $119,132 - $146,624
-1,580 Reduced 35.58%
2,861 $261,000
Q1 2019

May 15, 2019
BUY
$75.32 - $86.15 $334,496 - $382,592
4,441 New
4,441 $426,000

Others Institutions Holding NVS

# of Institutions
1,426
Shares Held
138M
Call Options Held
1.48M
Put Options Held
1.54M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $245B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Aptus Capital Advisors, LLC Portfolio

Follow Aptus Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aptus Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aptus Capital Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email